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Background: Immunomodulators are substances that modify immune system response to a threat.
Immunomodulators modulate and potentiate the immune system, keeping it highly prepared for any threat. The
immunomodulatory effect of the traditional medicine Tinospora crispa is investigated in this work.
Methods: T. crispa ethanol extract was fractionated by using different solvents. The ethanol extract and effective
isolated fraction were used to investigate the potential immunomodulatory effect of different T. crispa doses
ranging from 25 μg/mL to 1000 μg/mL on RAW 246.7 cells by detecting intracellular INF-γ, IL-6, and IL-8 expressions.
The antioxidant activity of T. crispa was evaluated through FRAP and DPPH. The total phenolic and total flavonoid
contents were also quantified.
Results: Results show that T. crispa extract has higher antioxidant potential than ascorbic acid. The FRAP value of
T. crispa extract is 11011.11 ± 1145.42 μmol Fe+2/g, and its DPPH inhibition percentage is 55.79 ± 7.9, with 22 μg/mL
IC50. The results also reveal that the total phenolic content of T. crispa extract is 213.16- ± 1.31 mg GAE/g dry stem
weight, and the total flavonoid content is 62.07- ± 39.76 mg QE/g dry stem weight. T. crispa crude extract and its
isolated fraction significantly stimulate RAW264.7 cell viability (P≤ 0.05) and intracellular INF-γ, IL-6, and IL-8 expressions.
The results of LC-MS show that four of the active compounds detected in the T. crispa isolated fraction are cordioside,
quercetin, eicosenoic acid (paullinic acid), and boldine.
Conclusions: The results of this study obviously indicate that T. crispa has immunomodulatory effects through the
stimulation of INF-γ, IL-6, and IL-8 expressions. LC-MS phytochemical analysis showed that the T. crispa fraction
has cordioside, quercetin, eicosenoic acid (paullinic acid), and boldine, which may be responsible for the
immunostimulator effect of T. crispa.
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The immune system is a remarkably developed defense
system that protects vertebrates from foreign bodies.
The immune system produces many cells and molecules
that distinguish and eliminate foreign and unwanted
agents. The modulation of the immune system refers to
any alteration in the immune response, including stimu-
lation, expression, amplification, or inhibition of any
portion or stage of the immune response. Therefore,* Correspondence: Mahmood955@yahoo.com
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on the immune system. Immunomodulators are grouped
into two types based on their effects: immunostimulators
and immunosuppressors. These immunomodulators
mount an immune response or defend against pathogens
or tumors [1]. Immunomodulators are substances that
modify the response of the immune system to a threat.
Immunomodulators modulate and potentiate the immune
system, keeping it highly prepared for any threat [2].
Plant extracts are commonly investigated in different
parts of the world for their possible immunomodu-
latory properties [3]. For example, Acorus calamus
rhizome extract inhibits the growth of several humanLtd. This is an Open Access article distributed under the terms of the Creative
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Figure 1 Tinospora crispa stem and leaves.
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interleukin-2 (IL-2) and tumor necrosis factor-α (TNF-α)
production, as well as downregulates CD25 marker expres-
sion [4]. Many plant-derived compounds, such as sterols,
sterolins, polysaccharides, alkaloids, flavonoids, lectin, and
glycoproteins, are used as immunomodulators [5,6].
The modulation of the immune response to treat
diseases has long been attracting attention. Numerous
recent studies have made advances in the research on
ethnomedicinal plants as immunomodulatory agents.
Immunopharmacology is a relatively new developing
branch of pharmacology that aims to identify immuno-
modulators. The possible uses of immunomodulators in
clinical medicine include the reconstruction of immune
deficit, such as AIDS treatment, and the suppression of
normal immune response or exaggerated immune re-
sponse in autoimmune diseases. Medicinal plants and
their active components are important sources of immu-
nomodulators. The development of immunomodulatory
and anti-tumor drugs from natural compounds has
attracted considerable interest [3].
Plants provide humans with food, dyes, perfumes,
gum, fibers, resins, and many other useful products.
Ethno-pharmacologists are currently paying more atten-
tion to the investigation of the bioactive properties and
phytochemical analysis of plants for the treatment of
various diseases. Several medicinal plants serve thera-
peutic functions in various diseases [7].
Many studies recently endorsed the use of traditional
medicinal plants to treat diseases. Plants reportedly pos-
sess various biological activities [8]. Genus Tinospora has
been known as a traditional medicine in Southeast Asia.
Tinospora has long been used in India as medication and
in the preparation of a starch known as gilae-ka-sat or
palo. Tinospora is a tonic, diuretic, and antiperiodic.
Tinospora crispa, which is abundant in the Philippines
under the name makabuhay, which means “You may
live”, can be easily used for general weakness, malarial
fevers, and chronic rheumatism. The whole plant has
the bitter alkaloid colombine, flavonoids, and a glucoside
[9]. Previous studies were performed to evaluate the
nutritional components and mineral content of T. crispa
stems. Results reveal that T. crispa contains high mois-
ture content of approximately 77.9% and carbohydrate
content of about 19.4%. Fat, protein, fiber, and ash are
present in the plant at low percentages. The most abun-
dant elements in the plant are calcium and potassium.
Other trace elements, such as silicon, magnesium,
chlorine, and phosphorus, are very low. The result also
shows that T. crispa extracts have high antioxidant
property. This result is confirmed by the existence of
phenolics and flavonoids, such as catechin, luteolin,
morin, and rutin, in the extract. These phenolics and fla-
vonoids are responsible for high antioxidant activity.Some studies suggest that T. crispa could be an import-
ant source of nutrients and natural antioxidants [10].
The various chemical components of T. crispa make it
useful for the treatment of different diseases. Many stud-
ies support the use of T. crispa stem extract as an anti-
parasitic. T. crispa stem extract has been used in vivo as
an antimalarial agent [11]. The antioxidant properties of
T. crispa stem extract make it useful for the treatment of
diseases resulting from oxidative stress, such as cardiovas-
cular diseases [12]. T. crispa is traditionally known as
an anticancer drug, such that many studies investigated
the anticancer activity of the plant. T. crispa has dose-
dependent anti-proliferative activity against MDA-MB-
231 cancer cells, HeLa cells, and human mammary cancer
cells (MCF-7) [13]. The aqueous crude extract of T. crispa
stems has anti-proliferative activity against the MCF-7 cell
line [14]. The immunomodulatory potential of the isolated
T. crispa fraction is investigated in this work.
Methods
Plant extraction
T. crispa dried stems; Figure 1 (harvested at the Selangor
housing area in the Herbarium of University Putra
in Malaysia, as voucher specimens: KLU 45568) were
crushed, and 100 g of the powder was placed in a conical
flask and soaked in 900 mL of 95% ethanol for 3 d at
room temperature (30 ± 2°C). The suspension was occa-
sionally shaken to completely dissolve the powder in
ethanol, which was denoted by the change in colour to
dark brown. The mixture was then filtered using a filter
paper (Whitman, 185 mm), and distilled under reduced
pressure in a rotary evaporator (Buchi, Switzerland). The
extract was stored at −20°C prior to use [15].
Profiling and fractionation of crude extracts
First, 1 g of ethanol crude extract was dissolved in 5 mL of
methanol and was subjected to column chromatography
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Scientific Glassware, Vineland, NJ, USA) packed with
silica gel G60, 70–230 mesh (Merck, Darmstadt,
Germany) linked to an EYEL-L4 pump (Tokyo Rikakikai,
Tokyo, Japan). Gradient concentrations of solvents
that differ in polarity (25 mL each of five different
concentrations: 20%, 40%, 60%, 80%, and 100%) were
used to elute the crude extract. The solvents used were
hexane, ethyl acetate, methanol, acetonitrile, and water
in order of increasing polarity. The yield fractions were
collected in clean class tubes and gathered based on
the solvent used. The solvents were evaporated from
the yield fractions under reduced pressure by using a
centrifuge evaporator.
Antioxidant and free radical study
Ferric reducing antioxidant power (FRAP)
This method was performed by preparing the working
FRAP reagent as described below:
1) The 300 mmol/L acetate (pH 3.6) buffer was
prepared by mixing 3.1 g of sodium acetate
trihydrate (C2H3NaO2:3H2O) with 16 mL of glacial
acetic acid/L of buffer solution.
2) The TPTZ solution was prepared by dissolving
10 mmol/L TPTZ in 40 mmol/L HCl.
3) We mixed 20 mmol/L FeCl3 × 6H2O with distilled
water.
4) The three reagents were mixed to a 10:1:1 ratio by
adding 25 mL of the acetate buffer, 2.5 mL of the
TPTZ solution, and 2.5 mL of the FeCl3 × 6 H2O
solution. The working solution must always be
freshly prepared.
5) Standards of known Fe(II) concentrations were
prepared. (FeSO4:7H2O) was run in triplicate for
calibration in several concentrations from 100 μmol/L
to 1000 μmol/L.
6) FRAP reagent was used as a blank.
Approximately 150 μL of the total FRAP reagent was
added to each well in a 96-well (300 μL) microplate. A
20 μL portion of the sample was then added to each
well in triplicate, and the absorbance at 593 nm was
measured after 15 min. The relative activities of the
samples were assessed by comparing their activities
with that of the Fe+2 equivalent [16].Redical scavenging activity test (DPPH)
The test was performed according to previous studies
[15]. The plant extract (1 mg) was dissolved in 1 mL of
95% ethanol to make a stock solution, and five dilutions
were prepared from the stock. L-Ascorbic acid standards
were prepared similar to the plant extracts. Approxi-
mately 5 μL from each dilution of plant extracts and
standard was added to 195 μL of DPPH, and the mixturewas loaded in a 96-well plate in triplicate for each sam-
ple. Ethanol was used as a blank. The plate was incu-
bated at room temperature for 2 h, and the absorbance
was read at 517 nm.
The antioxidant activity was calculated as the DPPH
radical scavenging activity (DPPH inhibition %) accord-
ing to the formula:
DPPH inhibition% ¼ ½ðabsorbance blank–absorbance
sampleÞ=absorbance blank  100
The graph of the concentration of the sample versus
the DPPH scavenging activity percentage was plotted to
evaluate IC50 (the concentration required to inhibit 50%
of the DPPH radical scavenging activity).
Total phenolic content
The total phenolic contents were determined as de-
scribed in [17], with some modifications in the solution
volumes to make them suitable for the microplate. A
10 μL portion from the extract prepared at 1 mg/mL
concentration was added to 100 μL of Folin–Ciocalteu
reagent (prepared beforehand at tenfold dilution with
deionized water), then mixed well and set aside for 5 min
at room temperature. Then, 100 μL of 10% sodium
carbonate was added to the mixture, which was then incu-
bated for 2 h at room temperature. The optical density
was read at 765 nm absorbance. Gallic acid was used
as the standard. The standard calibration (0 mg/mL to
200 mg/mL) curve was plotted using gallic acid. The total
phenolic content is expressed as gallic acid equivalent in
mg/g of dry sample or mg GAE/g sample.
Estimation of total flavonoid content
The aluminum chloride colorimetric method was used
as described by [18] to determine flavonoid content. The
method was applied by mixing 0.5 mL of plant extract
(1 mg/mL), 1.5 mL of methanol, 0.1 mL of 10%
aluminum chloride, 0.1 mL of 1 M potassium acetate,
and 2.8 mL of distilled water. The mixture was set aside
at room temperature for 30 min. The absorbance of the
mixture was measured at 415 nm. A calibration curve
was established to calculate total flavonoid content. The
calibration curve was plotted by preparing different
concentrations (0 mg/mL to 200 mg/mL) of quercetin in
methanol. The total flavonoid content is expressed as
quercetin equivalent in mg/g of dry sample or mg QE/g
sample.
Immunomodulatory effect in vitro
Cell line
A murine macrophage cell line RAW264.7 obtained
from American Type Culture Collection (ATCC, Rockville,
MD) was cultured in DMEM supplemented with 4500 g
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lin–streptomycin (Sigma-Aldrich, UK), and 10% heat-
inactivated fetal bovine serum (FBS) (J R Scientific, Inc.,
USA). The cells were cultured at 37°C in a 5% CO2 atmos-
phere incubator (NuAire, Plymouth, MN, USA). The cells
were subcultured when at 80% confluence, and the cell
suspension was diluted to 5 × 105 cells/mL for the experi-
ments [19]. One hour before the experiments, 1 mL of
fresh medium (37°C) was placed on the six-well plates
(Costar, Corning, NY). The cells were cultured for 24 h.
Proliferation assay
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay (Merck, Germany) was used to
determine the effect of plant extract and isolated frac-
tions on RAW264.7 cell proliferation. The MTT test
measures the capability of cells to convert MTT to
formazan. The cells were plated in 96-well tissue culture
plates at a density of 5 × 105 cells/mL, 5000 cells/well
in complete DMEM medium and incubated in triplicate
in a 96-well plate at a final volume of 100 μL for 24 h
at 37°C and 5% CO2 conditions [20]. The cells were
treated with plant crude extract, and all fractions at the
final concentrations of 25, 50, 100, 200, 400, 800 and
1000 μg/mL were incubated for 24 h at 37°C and 5%
CO2. Then, 10 μL of 5 mg/mL phosphate-buffered saline
(PBS) MTT solution was added to each well. After 4 h of
incubation at 37°C, the media and MTT were aspirated,
and 100 μL of dimethyl sulfoxide (Fisher Scientific, UK)
was added to dissolve the yellow MTT tetrazolium salt
produced by metabolism to acquire purple MTT forma-
zan salt. The amount of MTT formazan salt produced is
proportional to the amount of viable cells, and the cell
proliferation rate is determined by measuring the ab-
sorbance at 570 nm using a microplate reader [19,21].
In vitro stimulation for intracellular cytokines production
The capability of the isolated fraction to stimulate cyto-
kine production in the RAW 264.7 cell was evaluated.
RAW 264.7 cells (1 × 106 cells/mL, 6 mL/well) were
incubated in a complete DMEM medium for 24 h at 37°C
in 5% CO2 [22]. The cells were treated with 1 μg/mL of
LPS (Escherichia coli 055: B5, Difco, Detroit, MI,USA),
1 μL/mL of brefeldin A (BD GolgiPlug™), 100 μg/mL of
T. crispa stem crude extract, and its more effective frac-
tion 100 μg/mL (T.c F2). The cells were incubated for
6 h [19,23]. The medium was removed before treatment
with 1 μg/mL of LPS, and cells were washed with 5 mL
of PBS and replenished with complete medium [24].
Cells treated with 1 μg/mL LPS alone were used as the
control [22]. After incubation, the cells were washed
twice with PBS and resuspended in 0.5 mL of staining
buffer PBS containing 1% FBS and 0.09% (w/v) sodium
azide [23].Flow cytometry immunostaining of intracellular cytokines
Cells were resuspended to 107 cells/mL density, and
100 μL aliquots of the cell suspension were transferred
into tubes for staining. The cell suspension was pre-
incubated with Mouse BD Fc Block™ purified anti-mouse
CD16/CD32 mAb 2.4G2 (BD Fc Block™; Cat. No.
553141) (1 μg/106 cells in 100 μL) at 4°C for 15 min to
reduce nonspecific immune fluorescence staining, and
the cells were fixed/permeabilized with 250 μL of
fixation/permeabilization solution (BD Cytofix/Cyto-
perm™ Plus Fixation/Permeabilization, BD Golgi Plug™
protein transport inhibitor, Cat. No.555028) for 20 min
at 4°C. The cells were washed twice with 1 mL of 1 ×
BD Perm/Wash™ buffer, 250 × g, for 5 min at 4°C. The
fixed/permeabilized cells were resuspended in 50 μL
of BD Perm/Wash™ buffer and then incubated with
fluorochrome-conjugated anti-cytokine antibodies, PE
Anti-Mouse IL-6 (≤0.25 μg/million cells, BD Cat. No:
554401), FITC Rat Anti-Mouse IFN-γ (≤0.5 μg/million
cells, BD Cat. No: 554411), and APC Rat Anti-Mouse
IL-8 (≤0.5 μg/million cells, BD Cat. No: FAB2164A) at
4°C for 30 min in the dark. The cells were washed
twice with 1× BD Perm/Wash™ buffer (1 mL/wash)
after incubation and then resuspended in staining buf-
fer before flow cytometric analysis.Identification of active constituents
High-resolution mass spectrometry was performed to
identify and characterize the active constituents in the
T. crispa fraction 2 (T. c F2) that has proliferation and
stimulation effects on RAW264.7 cells. High-resolution
mass spectra were recorded on an LC-Mass (Agilent
technologies 6530 Accurate-Mass QTOF LC/MC), using
MeOH-Water (40:60) as the eluent. The high resolution
mass spectra confirms the identity of the extracted active
compounds using [M +H]+, [M +Na]+, [M + K]+, and
[M +NH3]
+ [25].Statistical analysis
The values are presented as mean ± standard division
(S.D.). The data are statistically analyzed through one-way
analysis of variance (ANOVA), univariate analysis of
variance, and post hoc LSD test (comparing the treated
groups with control), with P ≤0.05 considered as statis-
tically significant.
The flow cytometry samples were analyzed using the
two-dimensional forward and side scatter of the flow
cytometer and fluorescence intensity using at least
10,000 cells collected from each sample. The cytokine
analysis was performed using FACS Canto II flow
cytometer and FACS Diva Version 6.1.3 software (BD
Biosciences).
Figure 2 Cell viability Percentage of RAW264.7 cell treated
groups of T. crispa compared to control (untreated group).
Each value represents the mean percent ± S.D.*significantly different
versus control group, P≤ 0.05.
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Quantitative and evaluation of antioxidant contents and
activity
The antioxidant activity of T. crispa, as evaluated by
FRAP and DPPH tests, are shown in Table 1. The total
phenolic and total flavonoid contents are also pre-
sented in Table 1. The results show that the T. crispa
extract has higher antioxidant activity than standard
ascorbic acid. The FRAP value of the T. crispa extract
is 11011.11 ± 1145.42 μmol Fe+2/g, whereas the value
for standard ascorbic acid is 7951.85 ± 330.42 μmol
Fe+2/g. The DPPH test detected 55.79 ± 7.9% DPPH
inhibition, and 22 μg/mL IC50 for T. crispa, and 69.03 ±
9.3% DPPH inhibition and 19 μg/mL IC50 for ascorbic
acid. The results reveal that the total phenolic content of
the T. crispa extract is 213.16 ± 1.31 mg GAE/g dry stem
weight and its total flavonoids content is 62.07 ± 39.76 mg
QE/g dry stem weight.
Proliferation effect on the RAW264.7 cell
The immunomodulatory effect of the crude extract and
five yield fractions of the plant on the RAW264.7
macrophage cell line was investigated. The results
prove that T. crispa stimulates RAW264.7 cell proli-
feration in a dose-dependent manner. Cell viability
significantly increased (P ≤ 0.05) with mean viable cell
percent ± SD values of 126.43 ± 2.91, 141.59 ± 1.8,
163.62 ± 3.26, 131.28 ± 0.65, 127.96 ± 1.45, and 108.18 ±
1.98 for 25, 50, 100, 200, 400, and 800 μg/mL
T. crispa doses, respectively. The results show no
significant increase in the cell viability at 1000 μg/mL
T. crispa (103.79 ± 1.79) dose after incubation for 24 h
compared with the control (Figure 2).
The immunomodulatory effect of the isolated frac-
tions on the RAW264.7 cell line was investigated, and
the best fraction was chosen to investigate its effect on
the intracellular expression of cytokines and was sub-
jected to LCMS profiling to identify the active constit-
uents. The effects of the five fractions of the plant on
RAW264.7 cell line proliferation were investigated.
The isolated fractions appear to have different effects
on RAW264.7 cell proliferation. The T. crispa (F1, F2,
and F5) treatments show significant dose-dependent
cell viability increase P ≤ 0.05. The viability percentage
significantly decreased P ≤ 0.05 in a dose dependent





Ascorbic acid 7951.85 ± 330.42 69.03 ± 9.3
T. crispa 11011.11 ± 1145.42 55.79 ± 7.9
Data here are expressed as mean ± standard deviation, FRAP value is expressed asF
phenolic content is expressed as Gallic acid equivalents (GAE), while the Total flavoafter the treatment of 24 h incubation with T. crispa
(F3 and F4) (Figure 3).
In vitro stimulation of intracellular cytokines production
The stimulation of intracellular INF-γ, IL-6, and IL-8
production were measured by flow cytometry on the
RAW264.7 macrophage cell stimulated with 1 μg/mL
of LPS and 100 μg/mL of each T. crispa extract and
T. crispa F2. The intracellular INF-γ expression signifi-
cantly (P ≤ 0.05) increased RAW264.7 cell stimulation
with T. crispa extract and T. crispa F2 at mean percent ±
SD 23.15 ± 4.25 and 22.95 ± 4.35, respectively, compared
with the control RAW264.7 cells treated with LPS
alone (Figure 4).
The results also show significant (P ≤ 0.05) increase
in intracellular IL-6 and IL-8 expressions with the
RAW264.7 cells treated with T. crispa extract and
T. crispa F2. Figure 5 shows that the mean percent ±
SD for intracellular IL-6 expression are 13.67 ± 6.17
and 13.90 ± 5.53 for T. crispa extract and T. crispa
F2, respectively and Figure 6 shows that the mean
percent ± SD for intracellular IL-8 intracellular are
16.0 ± 3.3 and 15.9 ± 2.5 for T. crispa extract and T.
crispa F2, respectively, compared with the control
RAW264.7 cells treated with LPS alone.
Investigation of active constituents
LC-MS was performed to identify the phenolic constitu-




contents mg TE/gIC50 μg/ml
19
22 213.16 ± 1.31 62.07 ± 39.76
e+2equivalents IC50 value for the DPPH assay expressed as μg/ml. Total
noid content is expressed as Trolox equivalents (TE).
Figure 3 Cell viability Percentage of RAW264.7 cell treated groups of T. crispa (T. c) F1, F2, F3, F4 and F5 compared to control
(untreated group). Each value represents the mean percent ± S.D.*significantly different versus control group, P ≤ 0.05.
Abood et al. BMC Complementary and Alternative Medicine 2014, 14:205 Page 6 of 12
http://www.biomedcentral.com/1472-6882/14/205Results show that approximately four compounds were
detected for T. crispa F2. The results show all peaks de-
tected with their retention times, observed m/z and the
m/z of fragment ions. The T. crispa F2 contains cordio-
side at m/z 511.2712 (Figure 7); quercetin at m/z
301.1422 and its fragments at m/z 123.0913, 185.1149,
and 155.1538 (Figure 8); eicosenoic acid (paullinic acid)
at m/z 311.1457 (Figure 9); and boldine at m/z 327.1576
and its fragment at m/z 251.1251 (Figure 10).Figure 4 Intracellular expression of INF-γ on RAW264.7 macrophage c
expression of INF-γ. The figures show the expression percent of INF-γ on R
(B) 1 μg/ml LPS + T. crispa 100 μg/ml. (C) LPS1μg/ml + T. crispa F2 100 μg
*Significant P≤ 0.05 versus control.Discussion
The modulation of immune response to combat diseases
has long been a topic of interest. Many recent studies
made progress in the research on ethnomedicinal plants
as immunomodulatory agents. Immunopharmacology is
a relatively new and developing branch of pharmacology
that aims to discover immunomodulators. The possible
uses of immunomodulators in medicine include the re-
habilitation of immune deficiency. Plant extracts haveell. Flow cytometry analysis was used to assess the intracellular
AW264.7 cell stimulated with (A) 1 μg/ml LPS alone as a control.
/ml. The number was represented the mean percent of the cell ± SD.
Figure 5 Intracellular expression of IL-6 on RAW264.7 macrophage cell. Flow cytometry analysis was used to assess the intracellular
expression of IL-6. The figures show the expression percent of IL-6 on RAW264.7 cell stimulated with (A) 1 μg/ml LPS alone as a control. (B) 1 μg/ml
LPS + T. crispa 100 μg/ml. (C) LPS1μg/ml + T. crispa F2 100 μg/ml. The number was represented the mean percent of the cell ± SD. *Significant
P ≤ 0.05 versus control.
Figure 6 Intracellular expression of IL-8 on RAW264.7 macrophage cell. Flow cytometry analysis was used to assess the intracellular
expression of IL-8. The figures show the expression percent of IL-8 on RAW264.7 cell stimulated with (A) 1 μg/ml LPS alone as a control. (B) 1 μg/ml
LPS + T. crispa 100 μg/ml. (C) LPS1μg/ml + T. crispa F2 100 μg/ml. The number was represented the mean percent of the cell ± SD. *Significant P≤ 0.05
versus control.
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Figure 7 Mass spectrum (TOF MS ES+) and chemical structure of cordioside (peak No. 1) identified in T. crispa F2.
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for their possible immunomodulatory properties. Some
studies demonstrate the isolation of potential bioactive
molecules [3].
Macrophages are the first line of defense in the innate
immunity against microbial infection, and phagocytes
engulf and kill microorganisms and present antigens that
elicit adaptive immune responses [26]. Macrophages
serve an important function in tissue remodeling through
development, wound healing, and tissue homeostasis.
Macrophages are essential to the innate immunity and
pathology of tissue injury and inflammation [27] through
phagocytosis. Macrophages secrete cytokines, such as
interleukins, TNF-α, and INFs, as well as inflammatory
mediators, such as nitric oxide [28]. Macrophages main-
tain homeostasis and serve an important function in the
host defense against pathogens and attacking cells, such
as cancer cells [29].Figure 8 Mass spectrum (TOF MS ES+) and chemical structure of quePlant extracts are widely investigated in different parts
of the world for their possible immunomodulatory prop-
erties. Some studies demonstrated the isolation of poten-
tial bioactive molecules [3]. Shosaiko-to, a Japanese herb,
possesses many ethopharmacological effects, such as
the modulation of numerous host immune responses.
Researchers suggest that its effect on hepatitis B might
be attributed to its capability to stimulate INFs and acti-
vate natural killer cell activity [30].
The effects of T. crispa and its isolated fractions on
inducing macrophages to release immunomodulatory
cytokines, such as INF-γ, IL-6, and IL-8, were deter-
mined. RAW 267.4 macrophage cells were used in this
study to determine the immunomodulatory activities by
determining their intracellular cytokine production.
The results of this study show that T. crispa and its iso-
lated fraction modulate immunity by increasing RAW
264.7 macrophage cell proliferation in a dose-dependentrcetin (peak No. 2) identified in T. crispa F2.
Figure 9 Mass spectrum (TOF MS ES+) and chemical structure of Eicosenoic acid (paullinic acid) (peak No. 3) identified in T. crispa F2.
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expression of cytokines INF-γ, IL-6, and IL-8. These
findings clearly indicate the significant immunomodula-
tory effect of the both the plant and its active fraction as
immunostimulators. These findings importantly show
that the isolated fraction from T. crispa is a very suitable
candidate for modulating macrophage function and in-
ducing the immune system. The literature shows that
immunomodulatory action is important in antitumor
activity [31]. Therefore, the isolated active fraction from
T. crispa in this study is a potential candidate for antitu-
mor treatment. Preliminary studies on the antiprolifera-
tive efficiency of the T. crispa extract support this
hypothesis [32].
The antioxidant activity in the plant has gained sig-
nificant attention in recent years for its function in
protecting cells from damage by oxidative stress. The
secondary metabolites of plants are the most biologic-
ally active natural compounds. Therefore, plants areFigure 10 Mass spectrum (TOF MS ES+) and chemical structure of bosources of food antioxidants, such as vitamin E, vitamin
C, phenolic acids, carotenes, and phytoestrogens. Polyphe-
nol or phenolic compounds are secondary metabolites
composed of one aromatic ring attached to one or more
hydroxyl groups. The molecules range from the simplest
molecules of phenolic acid to more complex compounds
(polymerized compounds), such as the flavonoids, lignins,
and tannins [33,34]. Plants are the major natural sources
of polyphenols (flavonoids and non- flavonoids), which
give color and flavor to the plants [35]. Phenolic com-
pounds are important in plants because the compounds
contribute to the defense against microbes. Flavonoids are
involved in UV filtration, symbiotic nitrogen fixation,
and floral pigmentation, aside from acting as chemical
messengers and regulators of physiological functions.
Some flavonoids act as growth inhibitors of organisms
that cause plant diseases [36]. T. crispa extract has high
antioxidant potential, aside from the high total phenolic
and total flavonoid content of the T. crispa extract.ldine (peak No. 4) identified in T. crispa F2.
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the antioxidant activity of medicinal plants and their
immunomodulatory potential. The phenolic and flavonoid
compounds in plants have high antioxidant properties and
immunomodulatory effects [37]. The exact mechanism
remains unclear, but a large body of evidence supports the
influence of antioxidant properties on immunomodu-
lation. In vitro and in vivo studies demonstrated the
regulatory effect of phenolic compounds on macrophage
modulation and inflammatory mediator secretion from
macrophages and other leucocytes [38]. Previous reports
show that long-term antioxidant intake increases the
antioxidant activity in the thymus, which in turn exhibits
enhanced superoxide dismutase and catalase activities
[39]. These activities probably stimulate a minor modifica-
tion towards a mildly oxidizing environment, which favors
lymphocyte maturation. The intake of this nutrition may
promote the differentiation of other immune cell subsets,
such as B cells, T cells, myeloid cells, natural killer cell,
and dendritic cells [40].
Inflammation is the response of tissues to injury, char-
acterized in the acute phase through increased blood
flow, vascular permeability and the accumulation of
fluid, leukocytes and inflammatory mediators, such as
cytokines. The immune response in the chronic phase is
characterized by the development of specific humoral
and cellular immune responses to pathogens at the site
of tissue injury. Many soluble factors participated in
leukocyte recruitment in the course of the both acute
and chronic inflammation processes by increasing the
expression of cellular adhesion molecules and chemoat-
traction. Many kinds these soluble mediators regulate
the activation of resident cells, such as fibroblasts, endo-
thelial cells, tissue macrophages, and mast cells. The
substances also activated the production of inflammatory
cells, including monocytes, lymphocytes, neutrophils,
and eosinophils [41]. The results of this study clearly
reveal that the treatments using the plant and its
fraction enhance immune response and stimulate the
production of essential mediator cytokines, such as
INF-γ, IL-6, and IL-8, which are important in the acute
and chronic inflammatory response. IL-6 is important
in the stimulation of acute phase protein synthesis in
the liver, acts as a growth factor for mature b cells,
stimulates their final maturation onto antibody-producing
plasma cells, is involved in T cell activation and differ-
entiation, and affects the induction of IL-2 receptor
expression. The functions of IL-6 in the acute phase
response include chronic inflammation, autoimmunity,
fibrogenesis, and endothelial cell dysfunction [42]. INF-γ
affects murine Kupffer cells, stimulates macrophages and
is involved in the development of Th1 cells. The cellular
effects of INF-γ include the up-regulation of pathogen rec-
ognition, antigen processing and presentation, inhibitionof viruses, inhibition of cellular proliferation, and modify-
ing apoptosis and immunomodulation [43]. IL-8 is a po-
tent neutrophil chemotactic factor. Many types of cells
produce large amounts of IL-8 in response to various
stimuli, such as pro-inflammatory cytokines, microorgan-
isms and their products, as well as environmental alter-
ation, including hypoxia and hyperoxia. IL-8 is the main
mediator in neutrophil-mediated acute inflammation and
has a wide range of actions on the different types of cells,
including endothelial cells, fibroblasts, monocytes, lym-
phocytes, and neutrophils. These functions suggest that
IL-8 has important roles in different pathological disor-
ders, such as chronic inflammation and cancer [44]. A
previous study [45] revealed that T. crispa has no effect on
NK cell activity. However, this study did not suggest that
T. crispa does not affect the other immune responses. This
study shows that T. crispa has an immunostimulatory
effect on the activated macrophage mediated by enhan-
cing expression of cytokines INF-γ, IL-6, and IL-8.
These cytokines are involved in lymphocytes cell activa-
tion, which may indirectly affect the activation of NK
cell type by inducing macrophages to secret the cyto-
kines, which consequently stimulate cell-mediated
immunity.
Many previous studies similarly revealed the same
effect of medicinal plants, algae, or their derivatives
compounds. Astragalus membranaceus polysaccharide
improves immune response in the host individual by
inducing IL-2, IL-12, and TNF-α secretion, as well as in-
hibits tumor progression in vivo [46]. Sargassum fusiforme
has the same effect in promoting immune response and in-
hibits the growth of lung adenocarcinoma in mice [47].
LC-MS was performed in this study to detect and
identify the possible bioactive components in the T.
crispa fraction that may have been responsible for its
immunomodulatory effect. The LC-MS results for T.
crispa F2 identified four compounds, including cordio-
side (C25H34O11), quercetin (C15H10O7), eicosenoic acid
(paullinic acid) (C20H38O2), and boldine (C19H21NO4).
Cordioside has been isolated from T. crispa, with three
other compounds, tinosporaside, columbin, and β-
hydroxyecdysone [48]. Many previous studies reported
the isolation and identification of the phenolic com-
pounds, alkaloids, flavonoid, diterpenes, and triterpenes
from T. crispa and showed their biological activities as
highly antioxidant compounds and antiproliferative and
anti-inflammatory activities [49]. An alkaloid isolated from
T. crispa has cytotoxic activity against Toxoplasma gondii
[50]. Borapetoside C, isolated from T. crispa, improved
insulin sensitivity in diabetic mice [51]. Praman et al. iso-
lated five compounds (uridine, adenosine, higenamine,
salsolinol, and tyramine) from T. crispa and proved the
effects of these compounds on the cardiovascular system,
particularly on the reduction of blood pressure [52].
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powerful antioxidant activity and many pharmaco-
logical applications as immunostimulators and anti-
cancer agents [53].
Eicosenoic acid (paullinic acid) is an omega-7 fatty
acid present in various plants. Omega fatty acids are
fatty acids that cannot be produced by the human body
and are essential for human health. Thus, omega fatty
acids must be acquired from food. Omega fatty acids are
important in brain function, growth, and development.
Research shows the effects of such acids on reducing
inflammation and lowering the risk of chronic diseases,
such as cancer, heart disease, and arthritis. Omega fatty
acid deficiency is accompanied by symptoms, such as
poor memory, fatigue, heart problems, dry skin, poor
circulation, and depression [54].
Boldine is an alkaloid. Research conducted during the
early 1990s showed that boldine is one of the most
potent natural antioxidants. Many studies focused on
the pharmacological properties of boldine. The antioxidant
activity of boldine inspired researchers to investigate its
effect as an anticancer, cytoprotective, anti-inflammatory,
anti-atherogenic, anti-diabetic, and vasorelaxing immuno-
modulator [55].Conclusions
T. crispa stimulates immune activity by increasing the
intracellular expression of cytokines INF-γ, IL-6, and
IL-8. The T. crispa fraction was determined through
LC-MS phytochemical analysis to contain the com-
pounds cordioside, quercetin, eicosenoic acid (paullinic
acid), and boldine, which may be responsible for the
immunostimulator potential of T. crispa. Therefore, this
plant is a candidate drug that deserves further develop-
ment and pharmacological studies as a new drug.
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